Evidence map›Paper›PMID 23862015›Full record

ArticleBiology open2013

hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression.

Sreedevi Avasarala, Michelle Van Scoyk, Jianbin Wang, Marybeth Sechler, Katherine Vandervest, Christine Brzezinski, Colin Weekes, Michael G Edwards, John Arcaroli, Richard E Davis and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. MicroRNAs in the DNA Damage/Repair Network and Cancer.International journal of genomics · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sreedevi AvasaralaDivision of Pulmonary and Critical Care Sciences, School of Medicine, University of Colorado, Anschutz Medical Campus , Aurora, CO 80045 , USA.
Michelle Van Scoyk
Jianbin Wang
Marybeth Sechler
Katherine Vandervest
Christine Brzezinski
Colin Weekes
Michael G Edwards
John Arcaroli
Richard E Davis
Rama Kamesh Bikkavilli
Robert A Winn
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USVeterans Health Administration · US

Funding

Role of the noncanonical WNT pathway in non-small cell lung cancerR01CA138528 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WINN, ROBERT A. · 2010 to 2014
$1.4M
Wnt 7a and Its Role in EMT and Lung Cancer MetastasisR21CA153268 · NCI · UNIVERSITY OF COLORADO DENVER · PI WINN, ROBERT A. · 2010 to 2011
$270k
NCI NIH HHS R01 CA138528NCI NIH HHS R21 CA153268
6 · The paper itself

Abstract

In non-small cell lung cancer cell lines, activation of β-catenin independent signaling, via Wnt7a/Frizzled9 signaling, leads to reversal of cellular transformation, reduced anchorage-independent growth and induction of epithelial differentiation. miRNA expression profiling on a human lung adenocarcinoma cell line (A549) identified hsa-miR29b as an important downstream target of Wnt7a/Frizzled9 signaling. We show herein that hsa-miR29b expression is lost in non-small cell lung cancer (NSCLC) cell lines and stimulation of β-catenin independent signaling, via Wnt7a expression, in NSCLC cell lines results in increased expression of hsa-miR29b. Surprisingly, we also identify specific regulation of hsa-miR29b by Wnt7a but not by Wnt3, a ligand for β-catenin-dependent signaling. Interestingly, knockdown of hsa-miR29b was enough to abrogate the tumor suppressive effects of Wnt7a/Frizzled9 signaling in NSCLC cells, suggesting that hsa-miR29b is an important mediator of β-catenin independent signaling. Finally, we show for the first time that hsa-miR29b plays an important role as a tumor suppressor in lung cancer by targeting murine double mutant 2 (MDM2), revealing novel nodes for Wnt7a/Frizzled9-mediated regulation of NSCLC cell proliferation.

Indexed as

Frizzled 9hsa-miR29bMDM2Non-small cell lung cancerp53Wnt7a

Identifiers

PMID23862015
PMCPMC3711035
OpenAlexW2106638444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.